About Abiraterone Acetate Tablets (Abiratas 500mg Tablet)
Experience the distinguished and opulent efficacy of ABIRATAS (Abiraterone Acetate Tablets 500mg) in your advanced prostate cancer treatment regimen. This hot-selling oral anti-cancer therapy is offered in a bargain pack-1 strip of 120 film-coated, oval tablets per box. With a soaring reputation in multiple international markets such as Canada, the USA, UK, Australia, and the EU, ABIRATAS stands as a hot deal for oncologists seeking quality. Manufactured to Indian Pharmacopoeia (IP) standards, these odorless, white to off-white tablets blend potent Abiraterone Acetate with select excipients for unmatched prescription-only care. Store below 30C to preserve its efficacy.
Specialized Application & Key Features
Abiraterone Acetate Tablets (Abiratas 500mg Tablet) are intended for oral administration, working directly within the system for pronounced effects in the management of metastatic castration-resistant prostate cancer. Their plant application is restricted to clinical and hospital settings under oncologist direction. The white to off-white, oval tablets are truly distinguished by their high strength, odorless formulation, and ease of oral intake, offering patients a convenient therapeutic option guided by professional supervision.
Sample, Certifications & Export Markets
ABIRATAS 500mg Tablet offers sample availability and boasts IP certification, underscoring its commitment to quality standards. Express Shipping options ensure timely delivery, meeting urgent medical needs across various markets. Packaged securely for preservation, these tablets cater predominantly to the high-value markets of the USA, Canada, UK, EU, and Australia. ABIRATAS enjoys robust demand due to its excellent market value and consistent presence among reputed international buyers, traders, and healthcare suppliers.
FAQ's of Abiraterone Acetate Tablets (Abiratas 500mg Tablet):
Q: How should Abiratas 500mg Tablets be administered?
A: Abiratas 500mg Tablets should be taken orally in combination with prednisone or prednisolone, precisely as directed by a qualified physician or oncologist to ensure optimal treatment efficacy.
Q: What is the main benefit of using ABIRATAS for prostate cancer?
A: ABIRATAS provides a targeted treatment for metastatic castration-resistant prostate cancer, helping to inhibit certain cancer cell activities and improve patient outcomes when used under prescribed medical supervision.
Q: When can a patient expect to receive their order internationally?
A: Thanks to express shipping services, international orders to markets like the USA, UK, Canada, and the EU are processed promptly, with delivery timelines depending on the destination and customs clearance procedures.
Q: What certifications ensure the quality of ABIRATAS 500mg Tablets?
A: ABIRATAS is manufactured according to the Indian Pharmacopoeia (IP) standards, confirming strict adherence to pharmaceutical quality and safety protocols, and is registered in multiple countries with established healthcare regulations.
Q: Where should ABIRATAS Tablets be stored to maintain their efficacy?
A: These tablets must be stored below 30C (86F) in a dry place, protected from moisture, to maintain their potency and ensure the full 24-month shelf life from the date of manufacture.
Q: What distinguishes ABIRATAS from other abiraterone products in the market?
A: ABIRATAS features opulent quality, high dosage strength, and is supplied in a convenient, hot-selling packaging of 120 tablets per box, making it a top choice among oncologists and patients internationally.